GIMAP4 Inhibitors
Chemical inhibitors of GIMAP4 can function through various mechanisms that impact the protein's role in T-lymphocyte survival and immune system regulation. Cyclosporin A, for instance, binds to cyclophilins and inhibits calcineurin, which is pivotal for T-cell activation. This disruption in the activation process indirectly leads to the functional inhibition of GIMAP4, given its involvement in T-cell survival. Similarly, rapamycin targets mTOR, which is integral to cell growth and survival pathways, resulting in reduced T-cell proliferation and indirectly inhibiting the function of GIMAP4. Sphingosine acts on the sphingolipid signaling pathways that regulate apoptosis and immune cell trafficking, respectively. By influencing these pathways, it can induce cell death or alter cell localization, thereby diminishing the functional presence of GIMAP4 in immune cells.
Staurosporine and Wortmannin, as protein kinase and PI3K inhibitors, promote T-cell apoptosis and disrupt survival signals, indirectly reducing the survival-promoting functions of GIMAP4. LY294002 operates similarly to Wortmannin, further impeding PI3K-dependent survival signaling. PD98059 and U0126, both inhibitors of the MEK/ERK MAPK pathway, play roles in lymphocyte proliferation and differentiation; their inhibitory actions can lead to GIMAP4 functional inhibition by impairing pathways critical for T-cell function. SP600125 and SB203580, targeting JNK and p38 MAPK respectively, alter stress response and inflammatory pathways essential for T-cell differentiation, indirectly affecting GIMAP4's role. Lastly, Go6983, a PKC inhibitor, disrupts T-cell activation and survival processes, leading to an inhibition of the signaling environment crucial for GIMAP4's function in T-lymphocyte maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that binds to cyclophilins. GIMAP4 is involved in T-lymphocyte survival, and cyclosporin A, by binding to cyclophilin, inhibits calcineurin, which is crucial for T-cell activation, thus indirectly leading to the functional inhibition of GIMAP4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and survival pathways. As GIMAP4 is implicated in immune system processes, rapamycin would result in reduced T-cell proliferation and survival, thereby functionally inhibiting GIMAP4 by reducing its role in T-cell maintenance. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine serves as a sphingolipid signaling molecule that can induce apoptosis. Since GIMAP4 is involved in the regulation of apoptosis in immune cells, sphingosine can lead to apoptotic cell death, thus indirectly reducing GIMAP4's functional presence in the cells. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. GIMAP4 is associated with T-cell survival, and staurosporine can induce T-cell apoptosis through kinase inhibition, thereby indirectly inhibiting the survival function of GIMAP4 within the immune cell populations. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, which is involved in cell survival and proliferation signaling. By inhibiting PI3K, it would diminish T-cell survival signals, thereby indirectly inhibiting the survival-promoting functions of GIMAP4 in immune cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor which, similar to wortmannin, would lead to reduced survival signaling in T-cells, thereby indirectly functionally inhibiting GIMAP4 by impacting the cellular context in which GIMAP4 operates. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is upstream of ERK in the MAPK pathway. The MAPK pathway is involved in lymphocyte proliferation and differentiation, and by inhibiting this pathway, PD98059 can indirectly lead to functional inhibition of GIMAP4 in T-cells. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the stress-activated MAPK pathway. JNK influences T-cell survival, and inhibition of JNK would affect these survival pathways, thus leading to an indirect functional inhibition of GIMAP4 by changing the intracellular signaling milieu. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK, which plays a role in inflammatory responses and T-cell differentiation. By inhibiting p38 MAPK, SB203580 could indirectly inhibit GIMAP4 by altering the signaling environment of T-cells, which GIMAP4 is known to be involved in. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a broad-spectrum protein kinase C (PKC) inhibitor. Given that PKC is involved in T-cell activation, Go6983 would inhibit PKC-mediated signaling, leading to a functional inhibition of GIMAP4 by impacting the T-cell activation and survival processes that GIMAP4 is part of. | ||||||